Katalog der Deutschen Nationalbibliothek

Neuigkeiten Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00
 
Neuigkeiten

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

 
 
 


Ergebnis der Suche nach: Placebo
im Bestand: Gesamter Bestand

41 - 50 von 9260
<< < > >>


Online Ressourcen 41 Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS
DeZern, Amy E.. - Freiburg : Universität, 2025
Online Ressource
Online Ressourcen 42 Placebo
Leipzig : Deutsche Nationalbibliothek, 2025
Online Ressource
Online Ressourcen 43 Placebo - the HUT recordings
Leipzig : Deutsche Nationalbibliothek, 2025
Online Ressource
Online Ressourcen 44 Placebo-Glaube
Michaeli, Stefan. - Norderstedt : BoD - Books on Demand, 2025, 1. Auflage
Online Ressource
Online Ressourcen 45 Placebos und Behandlungsvertrag
Wolf, Annabelle. - Tübingen : Mohr Siebeck, 2025, 1. Aufl
Online Ressource
Online Ressourcen 46 Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson’s disease (ROCK-PD)
Wolff, Andreas W.. - Leipzig : Universitätsbibliothek Leipzig, 2025
Online Ressource
Online Ressourcen 47 Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab – a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)
Rauber, Conrad. - Augsburg : Universität Augsburg, 2025
Online Ressource
Online Ressourcen 48 Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy
Flöge, Jürgen. - Aachen : Universitätsbibliothek der RWTH Aachen, 2025
Online Ressource
Online Ressourcen 49 Rapid itch improvement and skin clearance with upadacitinib versus placebo (measure up 1 and measure up 2) and versus dupilumab (heads up): results from three phase 3 clinical trials in patients with moderate-to-severe atopic dermatitis
Simpson, Eric L.. - Freiburg : Universität, 2025
Online Ressource
Online Ressourcen 50 RETRACTED: Treatment effects in pharmacological clinical randomized controlled trials are mainly due to placebo
Schmidt, Stefan. - Freiburg : Universität, 2025
Online Ressource


41 - 50 von 9260
<< < > >>


E-Mail-IconAdministration